Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

1.2K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.2K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

861
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
861
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

18
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
18
Introduction to Hemostasis01:05

Introduction to Hemostasis

8.7K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
8.7K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

9.0K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
9.0K
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

37
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
37

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bone Mineral Density, Bone Remodeling Biomarkers, and Hemostatic Correlates in Hemophilia and von Willebrand Disease.

Blood advances·2026
Same author

Effects of Adoption of Race-Neutral Predictive Equations on Spirometry Results in Children With Sickle Cell Disease.

Pediatric blood & cancer·2025
Same author

Sociodemographic Characteristics of Patients Seen at Vascular Anomaly Centers in the United States.

Pediatric blood & cancer·2025
Same author

What is in a name: defining pediatric refractory ITP.

Blood advances·2024
Same author

Treatment practices and response in kaposiform hemangioendothelioma: A multicenter cohort study.

Pediatric blood & cancer·2023
Same author

Pharmacokinetics of bleomycin sclerotherapy in patients with vascular malformations.

Pediatric blood & cancer·2022

Related Experiment Video

Updated: Aug 29, 2025

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
04:56

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients

Published on: August 4, 2023

832

How we approach coagulopathy with vascular anomalies.

Joana M Mack1,2, Shelley E Crary1,2

  • 1Department of Pediatrics, Division of Hematology/Oncology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.

Pediatric Blood & Cancer
|September 7, 2022
PubMed
Summary

Vascular anomalies can cause bleeding and clotting disorders like Kasabach-Merritt phenomenon. This review explores managing these hematologic complications in patients with vascular anomalies.

Keywords:
bleedingcoagulopathythrombosisvascular anomalies

More Related Videos

Tissue Engineering by Intrinsic Vascularization in an In Vivo Tissue Engineering Chamber
09:55

Tissue Engineering by Intrinsic Vascularization in an In Vivo Tissue Engineering Chamber

Published on: May 30, 2016

9.0K
Accurate and Simple Evaluation of Vascular Anastomoses in Monochorionic Placenta using Colored Dye
09:52

Accurate and Simple Evaluation of Vascular Anastomoses in Monochorionic Placenta using Colored Dye

Published on: September 5, 2011

27.0K

Related Experiment Videos

Last Updated: Aug 29, 2025

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
04:56

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients

Published on: August 4, 2023

832
Tissue Engineering by Intrinsic Vascularization in an In Vivo Tissue Engineering Chamber
09:55

Tissue Engineering by Intrinsic Vascularization in an In Vivo Tissue Engineering Chamber

Published on: May 30, 2016

9.0K
Accurate and Simple Evaluation of Vascular Anastomoses in Monochorionic Placenta using Colored Dye
09:52

Accurate and Simple Evaluation of Vascular Anastomoses in Monochorionic Placenta using Colored Dye

Published on: September 5, 2011

27.0K

Area of Science:

  • Vascular anomalies and hematology

Background:

  • Vascular anomalies can lead to severe hematologic issues, including Kasabach-Merritt phenomenon (KMP) and localized intravascular coagulopathy (LIC).
  • These conditions arise from stagnant blood flow, promoting coagulation factor activation and consumption, leading to bleeding and thrombosis.
  • Patients face significant morbidity from pain and increased risk during surgery due to these coagulopathies.

Purpose of the Study:

  • To review and discuss the management strategies for coagulopathy in patients with vascular anomalies.
  • To address the lack of established standards of care for these hematologic complications.

Main Methods:

  • Literature review focusing on coagulopathy management in vascular anomalies.
  • Analysis of clinical presentations and complications such as KMP and LIC.
  • Synthesis of current approaches to managing bleeding and clotting in affected patients.

Main Results:

  • Vascular anomalies present complex hematologic challenges, including KMP and LIC.
  • Coagulopathy management in these patients lacks standardized protocols.
  • Patients experience high morbidity due to thrombosis-related pain and surgical risks.

Conclusions:

  • Effective management of coagulopathy is crucial for patients with vascular anomalies.
  • Further research and development of standardized care protocols are needed.
  • This review provides insights into current approaches for managing these hematologic aberrations.